Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Inventory Average (2019 - 2025)

Historic Inventory Average for Sunshine Biopharma (SBFM) over the last 7 years, with Q3 2025 value amounting to $13.5 million.

  • Sunshine Biopharma's Inventory Average rose 4789.86% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 4789.86%. This contributed to the annual value of $8.5 million for FY2024, which is 8851.44% up from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Inventory Average is $13.5 million, which was up 4789.86% from $12.4 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Inventory Average registered a high of $13.5 million during Q3 2025, and its lowest value of $25215.5 during Q1 2021.
  • For the 5-year period, Sunshine Biopharma's Inventory Average averaged around $4.8 million, with its median value being $4.0 million (2023).
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 233776.06% in 2023, then skyrocketed by 4789.86% in 2025.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Inventory Average stood at $88480.0 in 2021, then surged by 1911.52% to $1.8 million in 2022, then surged by 188.01% to $5.1 million in 2023, then soared by 105.81% to $10.5 million in 2024, then rose by 28.36% to $13.5 million in 2025.
  • Its Inventory Average stands at $13.5 million for Q3 2025, versus $12.4 million for Q2 2025 and $11.6 million for Q1 2025.